IQVIA (IQV) Competitors $186.79 -0.02 (-0.01%) Closing price 03:59 PM EasternExtended Trading$186.72 -0.07 (-0.04%) As of 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IQV vs. BRKR, ICLR, MEDP, TECH, A, CRL, DHR, MTD, TMO, and WATShould you be buying IQVIA stock or one of its competitors? The main competitors of IQVIA include Bruker (BRKR), Icon (ICLR), Medpace (MEDP), Bio-Techne (TECH), Agilent Technologies (A), Charles River Laboratories International (CRL), Danaher (DHR), Mettler-Toledo International (MTD), Thermo Fisher Scientific (TMO), and Waters (WAT). IQVIA vs. Its Competitors Bruker Icon Medpace Bio-Techne Agilent Technologies Charles River Laboratories International Danaher Mettler-Toledo International Thermo Fisher Scientific Waters IQVIA (NYSE:IQV) and Bruker (NASDAQ:BRKR) are related companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings. Is IQV or BRKR more profitable? IQVIA has a net margin of 7.88% compared to Bruker's net margin of 2.31%. IQVIA's return on equity of 30.05% beat Bruker's return on equity.Company Net Margins Return on Equity Return on Assets IQVIA7.88% 30.05% 6.77% Bruker 2.31%17.89%5.38% Which has more volatility and risk, IQV or BRKR? IQVIA has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Do institutionals & insiders hold more shares of IQV or BRKR? 89.6% of IQVIA shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 1.6% of IQVIA shares are owned by insiders. Comparatively, 27.3% of Bruker shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer IQV or BRKR? In the previous week, IQVIA had 16 more articles in the media than Bruker. MarketBeat recorded 24 mentions for IQVIA and 8 mentions for Bruker. IQVIA's average media sentiment score of 1.22 beat Bruker's score of 1.19 indicating that IQVIA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IQVIA 17 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bruker 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better valuation and earnings, IQV or BRKR? IQVIA has higher revenue and earnings than Bruker. IQVIA is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIQVIA$15.41B2.06$1.37B$6.9127.03Bruker$3.37B1.45$113.10M$0.5261.75 Do analysts prefer IQV or BRKR? IQVIA presently has a consensus price target of $229.64, suggesting a potential upside of 22.94%. Bruker has a consensus price target of $51.30, suggesting a potential upside of 59.76%. Given Bruker's higher probable upside, analysts plainly believe Bruker is more favorable than IQVIA.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IQVIA 0 Sell rating(s) 6 Hold rating(s) 18 Buy rating(s) 0 Strong Buy rating(s) 2.75Bruker 0 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.45 SummaryIQVIA beats Bruker on 13 of the 16 factors compared between the two stocks. Get IQVIA News Delivered to You Automatically Sign up to receive the latest news and ratings for IQV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IQV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IQV vs. The Competition Export to ExcelMetricIQVIAMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$31.76B$6.78B$5.75B$21.52BDividend YieldN/A1.20%5.89%3.50%P/E Ratio27.0326.5876.6629.87Price / Sales2.06191.58492.3053.57Price / Cash11.2521.7137.2224.68Price / Book5.594.9413.944.54Net Income$1.37B$178.07M$3.29B$999.97M7 Day Performance1.53%5.46%0.63%1.44%1 Month Performance-2.30%6.81%4.32%4.66%1 Year Performance-22.17%17.67%84.13%14.11% IQVIA Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IQVIQVIA4.9437 of 5 stars$186.790.0%$229.64+22.9%-21.9%$31.76B$15.41B27.0388,000Positive NewsBRKRBruker4.981 of 5 stars$30.80-0.1%$51.30+66.6%-49.1%$4.67B$3.37B59.2311,396Positive NewsShort Interest ↑ICLRIcon4.0243 of 5 stars$177.81+1.7%$219.64+23.5%-41.4%$14.36B$8.28B18.2941,900MEDPMedpace4.3162 of 5 stars$492.09+1.0%$412.73-16.1%+37.6%$13.82B$2.11B36.595,900TECHBio-Techne4.9831 of 5 stars$54.11-0.6%$70.42+30.1%-30.7%$8.48B$1.22B117.633,100Positive NewsAAgilent Technologies4.4632 of 5 stars$128.13-0.5%$139.25+8.7%-8.0%$36.32B$6.51B30.0817,900Analyst ForecastAnalyst RevisionCRLCharles River Laboratories International4.6147 of 5 stars$161.97-1.2%$175.69+8.5%-25.6%$7.97B$4.05B-121.7820,100Positive NewsDHRDanaher4.9894 of 5 stars$198.74-0.7%$246.35+24.0%-31.0%$142.31B$23.88B42.2963,000Positive NewsMTDMettler-Toledo International4.1097 of 5 stars$1,314.38+0.7%$1,311.11-0.2%-8.4%$27.07B$3.87B33.2817,300Positive NewsTMOThermo Fisher Scientific4.9754 of 5 stars$487.11-1.1%$589.38+21.0%-21.7%$183.94B$42.88B28.17125,000Positive NewsWATWaters4.7497 of 5 stars$309.58+1.1%$378.73+22.3%-7.7%$18.43B$2.96B27.927,600Trending News Related Companies and Tools Related Companies Bruker Alternatives Icon Alternatives Medpace Alternatives Bio-Techne Alternatives Agilent Technologies Alternatives Charles River Laboratories International Alternatives Danaher Alternatives Mettler-Toledo International Alternatives Thermo Fisher Scientific Alternatives Waters Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:IQV) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IQVIA Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IQVIA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IQV Stock Alerts